Medicine
Acetazolamide 500 mg/5 mL powder for injection
Acetazolamide 500 mg/5 mL powder for injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Acetazolamide
- Brand
- Sold under the generic name
- Strength
- 500 mg/5 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 5 mL, 1 vial and 4 more
- Manufacturers
- Avet PharmaceuticalsIndiaGland PharmaIndiaMylan InstitutionalSagent PharmaceuticalsXGen Pharmaceuticals DJB
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) excursions permitted between 15° to 30°C (59° to 86°F). Reconstituted solution should be stored in refrigerator at 2° to 8°C (36° to 46°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EC01 Acetazolamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 December 2008
- Identifiers
- RxCUI 307702DailyMed set ID 60f656ff-97b1-4a89-99af-8100483c2bac, 4dd56001-4941-4ff0-9f30-02a1bcc4fe7e, a9199d3c-ce52-4db5-aa36-408f4e15e344 +4NDC 23155-313, 23155-831, 39822-0190 +4Application ANDA202693, ANDA040784, ANDA219775 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 mL in 1 vial, glass | 23155-313-31 | Avet PharmaceuticalsIndia | 6 October 2021 |
| 1 vial, glass in 1 carton / 5 mL in 1 vial, glass | 23155-831-31 | Avet PharmaceuticalsIndia | 15 November 2022 |
| 1 vial in 1 carton / 5 mL in 1 vial | 68083-661-01 | Gland PharmaIndia | 17 June 2025 |
| 1 vial in 1 carton / 5 mL in 1 vial | 67457-853-50 | Mylan Institutional | 13 September 2018 |
| 1 vial in 1 carton / 5 mL in 1 vial | 72078-092-50 | Mylan Institutional | 1 September 2026 |
| 1 vial in 1 carton / 5 mL in 1 vial | 25021-839-20 | Sagent Pharmaceuticals | 15 January 2026 |
| 1 vial, glass in 1 carton / 5 mL in 1 vial, glass | 39822-0190-1 | XGen Pharmaceuticals DJB | 1 March 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 July 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Acetazolamide
Clinical summary
Acetazolamide is a carbonic anhydrase inhibitor indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those, among other approved uses. MedsAcross supplies Acetazolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcetazolamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Acetazolamide prescribing information (Lifestar Pharma) · U.S. National Library of Medicine, DailyMed
Need Acetazolamide 500 mg/5 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.